glp 1 weight loss drugs What Are the Side Effects of GLP-1 Drugs? A new pill form of

Large-Scale Real-World Analysis In this retrospective cohort study, researchers analysed data from more than 740,000 patients with Type 2 diabetes using the TriNetX Research Network

Obes Surg 34(10):38883896 Kellett J et al (2025) The efficacy of glucagon-like peptide-1 (GLP-1) receptor agonists for insufficient weight loss or regain after metabolic/bariatric surgery: a systematic review and meta-analysis

ULTRABRN is similar to these effective injections but can be taken orally, so you can avoid both the needle and the cost

The ozempic segment dominated the market in 2025 with 32.15% share due to its strong clinical performance, high brand recognition, and widespread adoption for managing type 2 diabetes

Alan Landay at the University of Texas Medical Branch